Agomab Therapeutics NV
AGMB$755M
Small CapNASDAQBiotechnology🇺🇸North America57 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Sep 15, 2026
26wMarket Overview
Stock performance and key metrics
AGMB News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
AGMB-129 | Phase 2 | Fibrostenotic Crohn's Disease | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply